J Clin Oncol 2012 Jul 11;30(21):e188-91. Epub 2012 Jun 11.
University of Cincinnati School of Medicine, Cincinnati, OH, USA.
Acta Dermatovenerol Croat 2020 Dec;28(7):210-214
Pedro Rodríguez-Jiménez, MD, Dermatology Department, Hospital Universitario de la Princesa, Madrid, Calle Diego de Leon 62, 28006 Madrid, Spain;
The body of literature supporting the use of Mohs micrographic surgery (MMS) in tumors outside the main indications (basal cell carcinoma, squamous cell carcinoma, dermatofibrosacroma protuberans, lentigo maligna) is constantly growing, but it is still based on case reports, case series, or at best institutional case series that focus on a single malignancy. Our aim in this review was to assess use of MMS in an array of rare tumors outside the usual indications. A review was performed using the MEDLINE database and the search engine ClinicalKey®. Read More
J Am Coll Surg 2021 Mar 13. Epub 2021 Mar 13.
Division of Surgical Oncology, Department of Surgery, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA. Electronic address:
Background: Malignant cutaneous adnexal tumors (MCATs) are rare and their natural history is poorly understood. Available literature indicates aggressive behavior with a significant risk of metastasis.Study Design: Retrospective review of our institutional surgical oncology databases was performed for patients diagnosed with MCATs (2001-2020). Read More
Head Neck 2020 09 21;42(9):2644-2659. Epub 2020 Apr 21.
Institute of Head and Neck Diseases, Evangelical Hospital Vienna, Vienna, Austria.
Background: The aim of the study is to analyze potential prognostic factors and to evaluate therapy strategies regarding clinical outcome in patients with eccrine porocarcinoma (EPC) of the head and neck.Methods: One hundred and sixteen EPC cases from ninety studies and four authors' EPC cases were included in the meta-analysis.Results: At an average follow up of 20. Read More
Dermatol Surg 2020 Mar 4. Epub 2020 Mar 4.
Department of Dermatology, Keck Medicine of University of Southern California, Los Angeles, California Keck Medicine of University of Southern California Los Angeles, California Department of Radiation Oncology, Keck Medicine of University of Southern California, Los Angeles, California Department of Medical Oncology, Keck Medicine of University of Southern California, Los Angeles, California Division of Mohs and Dermatologic Surgery, Department of Dermatology, Keck Medicine of University of Southern California, Los Angeles, California.
Int J Dermatol 2020 Mar 28;59(3):321-325. Epub 2019 Nov 28.
Hospital La Paz, Madrid, Spain.
Background: The use of Mohs micrographic surgery (MMS) for rare cutaneous tumors is poorly defined. We aim to describe the demographics, tumor presentation and topography, surgery characteristics and complications of MMS for rare cutaneous tumors in a national registry.Methods: Prospective cohort study of patients treated with MMS in Spain between July 2013 and June 2018. Read More